These Companies’ Insiders Rushed Out To Buy More Shares

Let’s now focus our discussion on biopharmaceutical company Celator Pharmaceuticals Inc. (NASDAQ:CPXX). Fred M. Powell, Chief Financial Officer and Vice President, purchased 13,700 shares at a weighted average price of $1.78, enlarging his position to 31,458 shares. A little more than a week ago, Celator Pharmaceuticals released a statement which revealed its positive research and development efforts towards using its proprietary technology to optimize the effectiveness of anticancer drug combinations using molecularly targeted agents. However, analysts believe that there is still a long way to go before Celator Pharmaceuticals and its peers will be able to bring their T-cell therapies to the market. At the same time, a potential investment into the stock may be associated with great risks, given that the company is not generating any revenue, while its losses continue to widen each quarter. Meanwhile, the shares of Celator are 12% in the red year-to-date, so the executive’s move might point to the fact that the potential of the company is not fully priced in. Chao Ku’s Nine Chapters Capital Management is the only investor from our database invested in Celator Pharmaceuticals Inc. (NASDAQ:CPXX).

Finally, NuStar Energy L.P. (NYSE:NS) saw three different insiders acquire shares last week. Mary Rose Brown, Chief Administrative Officer and Executive Vice President since April 2013, purchased 2,332 shares at prices ranging between $42.12 and $43.77, and currently owns 49,344 shares. Moreover, President and CEO Brandley C. Barron added 2,400 shares, acquired at $42.13 apiece, to his holding that is now comprised of 34,153 shares. Lastly, Director Jesse D. Bates reported the acquisition of 1,000 shares at a price of $43.93 per share, all of which were acquired by a trust fund that now owns 20,062 shares. The Director also owns a direct ownership stake of 7,338 shares. The shares of the pipeline operator have had a rough year thus far, declining by over 14% since the beginning of the year. Therefore, it might be the case that the aforementioned Director and executives are buying the shares on weakness. Jim Simons’ Renaissance Technologies is bullish on NuStar Energy L.P. (NYSE:NS), owning slightly more than 165,000 shares.

Disclosure: None